DOSSIER · 13F-HR · Q2 2026

Royalty Pharma Sub-Manager, LLC

$242M in tracked AUM across 4 positions as of Q2 2026.

RP
CIK 0002081668 · last filed Jun 30, 2026
Total AUM
$242M
as of Q2 2026
Holdings
4
positions
Whale Score
71
71
strong
Activity
no data
changes this Q
AI Analysis · Q2 2026

Royalty Pharma Sub-Manager, LLC filed its latest 13F-HR for Q2 2026. See the latest holdings and position changes below.

Quarter at a glance — Q2 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q2 2026.

#HoldingValueSharesWeight
01
CYTK
CYTOKINETICS, INC
$84M980K34.5%
02
ZBIO
ZENAS BIOPHARMA, INC.
$61M2.4M25.1%
03
KLRA
KAILERA THERAPEUTICS
$54M2.5M22.4%
04
G1110E107
BIOHAVEN LTD
$44M2.9M18.1%

Filing history

2026Q2Jun 30
$242M 40.0%
4 positionsView →
2026Q1Mar 31
$173M 0.8%
4 positionsView →
2025Q4Dec 31
$171M
4 positionsView →